Bizarre Patents
A method of swing on a swing is disclosed, in which a user positioned on a standard swing suspended by two chains from a substantially horizontal tree branch induces side to side motion by pulling alternately on one chain and then the other.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7153511 | Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine The present invention provides an avian recombinant herpesvirus modified by the presence of the cDNA encoding, the VP2 of the Delaware Variant E strain of IBDV, a subtype of IBDV serotype 1 strains. The present invention further provides an avian recombinant herpesv... | 12/26/2006 |
| 7090854 | Chicken anaemia viruses of low pathogenicity The present invention provides a new antigenic type of chicken anaemia viruses (CAV). The CAV according to this invention is isolatable from turkeys in the field and its virulence for chickens is significantly reduced. This property makes these viruses particularly ... | 08/15/2006 |
| 6764684 | Avian herpesvirus-based recombinant infectious bursal disease vaccine The present invention provides an avian recombinant herpesvirus modified by the presence of the cDNA encoding the VP2 of the Delaware Variant E strain of IBDV, a subtype of IBDV serotype 1 strains. The present invention further provides an avian recombinant herpesvi... | 07/20/2004 |
| 6723324 | Chicken anaemia viruses of low pathogenicity The present invention provides a new antigenic type of chicken anaemia viruses (CAV). The CAV according to this invention is isolatable from turkeys in the field and its virulence for chickens is significantly reduced. This property makes these viruses particularly ... | 04/20/2004 |
| 6479056 | Live vaccine constituting minor risk for humans A salmonella live vaccine produced from at least one attenuated immunologic live vaccine strain, characterized in that the vaccine strain has an envelope marker which results in an increased sensitivity of the vaccine strain toward a specific therapeutica... | 11/12/2002 |
| 6458363 | Method to produce inactivated w/o emulsion adjuvated vaccines The present invention is directed to a method to prepare an inactivated w/o emulsion adjuvated vaccine, wherein an aqueous solution comprising one or more inactivated angigens is mixed under mild conditions with a ready-made w/o emulsion. Preferably the v... | 10/01/2002 |
| 6361775 | Compositions and methods for vaccines comprising -galactosyl epitopes The invention encompasses methods and compositions for inducing an immune response in an anti-Gal synthesizing animal including viral and tumor antigens manipulated to express -galactosyl epitopes.... | 03/26/2002 |
| 6312696 | Antigenic protein originating in infectious laryngotracheitis virus The present invention discloses a DNA molecule that encodes a polypeptide that has the amino acid sequence described in SEQ ID No. 2 or an amino acid sequence that is at least 80% homologous with said amino acid sequence, a recombinant containing said DNA... | 11/06/2001 |
| 6306400 | Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis The avian recombinant live vaccine comprises, as vector, an ILTV virus comprising and expressing at least one heterologous nucleotide sequence, this nucleotide sequence being inserted into the insertion locus formed by the intergenic region situated betwe... | 10/23/2001 |
| 6270770 | Chicken anaemia agent broiler vaccine The present invention for the first time discloses a health problem in broilers at about 3-5 weeks, resulting in significant production losses, and demonstrates that these production losses can be prevented by a live attenuated CAA vaccine for mucosal adm... | 08/07/2001 |
| 6241991 | Aviadenovirus The invention relates to a new aviadenovirus which was isolated from a pigeon. The aviadenovirus according to the present invention comprises group-I specific antigen and cannot be neutralized by antiserum against any of the FAV serotypes 1-12. The presen... | 06/05/2001 |
| 6231868 | Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts A system for the generation of live, nonpathogenic Birnavirus such as infectious bursal disease virus (IBDV), a segmented double-stranded (ds)RNA virus of the Birnavirdae family, using synthetic transcripts derived from cloned DNA has been developed. Inde... | 05/15/2001 |
| 6153199 | Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus The living recombinant avian vaccine comprises, as a vector, an ILTV virus comprising and expressing at least one heterologous nucleotide sequence, this nucleotide sequence being inserted in the insertion locus defined between the nucleotides 1624 and 360... | 11/28/2000 |
| 6129920 | Inactivated infectious bursal disease vaccine The present invention is concerned with Infectious bursitis virus (IBDV) vaccines containing IBDV antigen material which is derived from a mammalian cell line infected with IBDV.... | 10/10/2000 |
| 6086892 | Poultry vaccine This invention relates to a novel infectious bronchitis virus (IBV) serotype and to attenuated IBV strains derived therefrom, and also to live or inactivated vaccines made using such IB virus. This invention also relates to a method for protecting poultry... | 07/11/2000 |
| 6048535 | Multivalent in ovo avian vaccine A multivalent poultry vaccine is provided having two or more live biological agents or microbial components. Each live biological agent or microbial component is effective in preventing or treating an avian disease, and the multivalent vaccine is safe and... | 04/11/2000 |
| 6019985 | Immunostimulation methods for providing disease protection in poultry Methods are provided for improved immunization against coccidiosis and other bacterial, viral, or parasitic diseases in poultry. One method includes administering a solution of Propionibacterium acnes suspended in normal saline to a chick at age day one, ... | 02/01/2000 |
| 6013261 | Recombinant Marek's disease virus (MDV) and vaccine A recombinant herpes virus is provided which efficiently expresses an exogenous protein of interest in an inoculated animal host to thereby endow the host with excellent immunization. A recombinant herpes virus which incorporates an exogenous gene express... | 01/11/2000 |
| 6001348 | Non-virulent Mycoplasma synoviae and vaccine thereof The present invention provides NAD-independent Mycoplasma synoviae of strain MS1. The invention also refers to microbiological cultures comprising Mycoplasma synoviae of this strain. Next to this, the invention refers to live vaccines derived from these s... | 12/14/1999 |
| 5993822 | Modified live avian polymavirus vaccine in psittacine birds The present invention provides a vaccine which is protective against avian polyomavirus infection in a bird which is classified as being a member of the Psittaciformes order which comprises an immunogenic amount of a modified live avian polyomavirus in a ... | 11/30/1999 |
| 5965139 | Chicken infectious anemia virus vaccine Novel sequences in the genome of a wild type isolate of chicken infectious anemia virus are described, The amino acid sequence of a polypeptide, VP1, encoded by a novel sequence is also disclosed. Additionally, disclosed are the unexpected properties of t... | 10/12/1999 |
| 5958424 | Recombinant chicken anemia virus particle Recombinant genetic information (DNA or RNA), comprising a Chicken Anemia Virus (CAV)-specific nucleotide sequence and the use thereof for diagnostics, vaccination or protein production. Recombinant CAV protein and the use thereof for diagnostics, vaccina... | 09/28/1999 |
| 5916879 | DNA transcription unit vaccines that protect against avian influenza viruses and methods of use thereof The present invention describes a reliably protective avian vaccine that contains a DNA transcription unit comprising a nucleic acid that encodes a viral protein. This effective and reliable avian vaccine significantly improves upon that which heretofore ... | 06/29/1999 |
| 5914113 | Inactivated vaccines The present invention is concerned with the preparation of improved inactivated vaccines, in particular of inactivated poultry vaccines. The immunogenicity of the inactivated immunogens in such vaccines is enhanced in case live CAV are administered in a c... | 06/22/1999 |
| 5888518 | Method for preventing and treating coccidiosis A method for preventing and treating parasitic infections in animals by administering a lysine analog, such as EACA, to the animals on a continuous basis. In the preferred embodiment, the method of the present invention is directed to preventing and treat... | 03/30/1999 |
| 5879675 | Compositions and methods for vaccines comprising -galactosyl epitopes The invention encompasses methods and compositions for inducing an immune response in an anti-Gal synthesizing animal including viral and tumor antigens manipulated to express -galactosyl epitopes.... | 03/09/1999 |
| 5871744 | Method for generating birnavirus from synthetic RNA transcripts A system for the generation of live Birnavirus such as infectious bursal disease virus (IBDV), a segmented double-stranded (ds)RNA virus of the Birnavirdae family, using synthetic transcripts derived from cloned DNA has been developed. Independent full-le... | 02/16/1999 |
| 5858368 | Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein A method of preparing a recombinant influenza vaccine using DNA technology is provided. The resulting vaccine is a multivalent, preferably trivalent, influenza vaccine based on a mixture of recombinant hemagglutinin antigens cloned from influenza viruses ... | 01/12/1999 |
| 5853733 | Recombinant herpesvirus of turkeys and uses thereof The present invention provides a recombinant herpesvirus of turkeys designated S-HVT-050 (ATCC Accession No. VR 2400). A vaccine is provided which comprises an effective immunizing amount of S-HVT-050 and a suitable carrier. A method of immunizing a fowl ... | 12/29/1998 |
| 5804195 | Vaccine comprising an infectious bursal disease virus MB, MB-1 or MB-2 strain Invention relates to a vaccine for the prevention of Infectious Bursal Disease in poultry comprising an effective immunizing amount of a live attenuated intermediately-pathogenic IBD virus belonging to the strain deposited at the ECACC under No. V92052301... | 09/08/1998 |
| 5762939 | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus A method of preparing a recombinant influenza vaccine using DNA technology is provided. The resulting vaccine is a trivalent influenza vaccine based on a mixture of recombinant hemagglutinin antigens cloned from influenza viruses having epidemic potential... | 06/09/1998 |
| 5750113 | Poultry vaccine This invention relates to a novel infectious bronchitis virus (IBV) serotype and to attenuated IBV strains derived therefrom, and also to live or inactivated vaccines made using such IB virus.... | 05/12/1998 |
| 5733556 | Newcastle disease virus combination vaccine The present invention provides a combination vaccine for use in the protection of poultry against ND comprising an expression system, such as a virus vector, expressing a NDV immunogenic protein, and a live NDV vaccine strain. It is demonstrated that such... | 03/31/1998 |
| 5728569 | Chicken anaemia agent vaccine The present invention provides a live and inactivated Chicken Anaemia Agent vaccine capable of evoking an immune response in a vaccinated chicken. The CAA virus of the vaccine is attenuated by serial passages in embryonated eggs.... | 03/17/1998 |
| 5693530 | Marek's disease virus nucleotide sequence and methods of use A novel nucleotide sequence in the genome of Marek's disease virus (MDV) containing an open reading frame, whose expression is associated with lytic infection and tumor cell development in MDV-infected cells, is described. Also described is the use of thi... | 12/02/1997 |
| 5686077 | Methods of immunization of poultry with vaccines against chicken anemia agent (CAA) The present invention provides a live and inactivated Chicken Anaemia Agent vaccine capable of evoking an immune response in a vaccinated chicken. The CAA virus of the vaccine is attenuated by serial passages in embryonated eggs.... | 11/11/1997 |
| 5676952 | Herpesviruses transformed to express GD in vitro Herpesviruses naturally deficient in gD, that is to say not expressing their gD gene in vitro or not possessing this gene, are transformed to express gD in vitro. This transformation by genetic recombination can consist in replacement of the natural promo... | 10/14/1997 |
| 5602022 | Production of infectious bursal disease virus in mammalian cell line A method of producing infectious bursal disease virus comprising culturing infectious bursal disease virus in a mammalian cell line for two to ten days.... | 02/11/1997 |
| 5565202 | Low enhancement serotype 2 vaccine for marek's disease A vaccine for Marek's disease using mutant strains of a serotype 2 field isolate, designated 471B/1, is disclosed. The mutant viruses, which are produced by serial passage of 471B/1 in cell culture, not only retain effective immunizing ability against Mar... | 10/15/1996 |
| 5518724 | Infectious bursal disease virus A new virus not neutralized or bound by monoclonal antibodies which are group neutralizing to all IBDV vaccines of current art, and capable of inducing infectious bursal disease in poultry is identified, in essentially pure form. A test kit, and assay for... | 05/21/1996 |
